| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |